Response of Mtor Inhibitor Associated with Mutation of FBXW7 Gene Identified by Comprehensive Genomic Profiling in Cervical Squamous Cell Carcinoma Supports Additional Therapy Opportunity for Select Patients with Treatment-Refractory, Recurrent Disease